Healthcare entity
Salesforce is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. Coverage clusters in health-it, which accounts for 2 of those 3, with the remainder spread across 1 other category. They are less corroborated than the beat average, carrying 2 original sources each against 3.2 for the same window.
Last mentioned: Aug 4, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 33 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Salesforce is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. Coverage clusters in health-it, which accounts for 2 of those 3, with the remainder spread across 1 other category. They are less corroborated than the beat average, carrying 2 original sources each against 3.2 for the same window. That works out to roughly 1.8 stories per week across a 12-day span. The 5.3 average consequence score is below the beat benchmark of 5.9 in the same window. This profile follows 3 Healthcare stories mentioning Veeva Systems across the period from March 4, 2026 to March 15, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 260 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Veeva Systems. Shared-story counts are live from our verified record — not editorial picks.
Market Maturity
Revenue reaches $3.2B TTM as the company targets a $20B total addressable market.
Vault Expansion
The company aggressively expands its Vault platform into clinical, quality, and regulatory sectors.
Initial Public Offering
Veeva Systems goes public, establishing itself as a leader in life sciences CRM.
Veeva Systems maintains a dominant position in the life sciences cloud market, serving 15 of the top 20 biopharma firms. While revenue growth has moderated to $3.2 billion, the company's $20 billion total addressable market and high switching costs position it as a resilient long-term play.
Source: Prosper Junior Bakiny (us) · fool.com
Veeva Systems is facing a wave of price target reductions from major analysts, including TD Cowen and Canaccord Genuity, reflecting caution over its platform transition. While management maintains a $6 billion revenue target for 2030, recent disclosures of competitive losses have tempered market enthusiasm.
Source: defenseworld.net · defenseworld.net
Eli Lilly and Veeva Systems emerge as dominant healthcare growth leaders for 2026, driven by the GLP-1 weight-loss revolution and cloud-based life sciences infrastructure. Meanwhile, SoundHound AI is positioning itself to disrupt medical administrative costs through generative voice AI and automated customer service solutions.
Source: Prosper Junior Bakiny (us) · Keithen Drury (us)
Veeva Systems is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
